Retatrutide is an injection that is administered once-weekly for the treatment of obesity and belongs in the same drug class as semaglutide (brand names Ozempic and Wegovy) and tirzepatide (brand names Mounjaro and Zepbound)
Additional Details SKU: N0104
Who It Is For Athletes recovering from tendon, ligament, or muscle injuries Post-surgical patients seeking accelerated healing (with physician approval) Patients with chronic joint pain, tendinopathy, or repetitive strain injuries Individuals with gut health issues BPC-157 specifically supports intestinal mucosal healing Active adults who want to reduce recovery time between training sessions Patients with chronic inflammatory conditions seeking systemic inflammation reduction What to Expect Week 1-2: Reduction in acute pain and inflammation at injury sites
Stage 3 - Treatment plan and prescription
Considering the potential for therapeutic development of (in)GSH, the established safety and tolerability data, biological plausibility, and pilot level clinical evidence of benefit are further supported with this demonstration that (in)GSH is able to augment brain GSH levels
A supplement that works through the microbiome is inherently more variable in its effects than a medication that directly activates receptors regardless of individual gut conditions
